ASXL2-targeted siRNA(Altamira)

N/A

Report date: 2025/09/04 16:37:59
NME

Base Information

Drug NameASXL2-targeted siRNA(Altamira)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPutative Polycomb group protein ASXL2 modulators
TargetsPutative Polycomb group protein ASXL2
Therapy Area/IndicationsObesityMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBermuda
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltamira Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAltamira Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A